IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
Abstract Head and neck cancer is the sixth most common cancer worldwide with a 5-year survival of only 65%. Targeting compensatory signaling pathways may improve therapeutic responses and combat resistance. Utilizing reverse phase protein arrays (RPPA) to assess the proteome and explore mechanisms o...
Guardado en:
Autores principales: | Christine E. Lehman, Adam Spencer, Sarah Hall, Jeremy J. P. Shaw, Julia Wulfkuhle, Emanuel F. Petricoin, Stefan Bekiranov, Mark J. Jameson, Daniel Gioeli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b347bf831e74651bf20811b8511fc1e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
por: Vincent Yeung, et al.
Publicado: (2021) -
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines
por: Aryan Stanley, et al.
Publicado: (2017) -
Rap1 can bypass the FAK-Src-Paxillin cascade to induce cell spreading and focal adhesion formation.
por: Sarah H Ross, et al.
Publicado: (2012) -
FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity
por: Simon Timbrell, et al.
Publicado: (2021) -
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy
por: Madoka Iida, et al.
Publicado: (2019)